(1 - 19 from 30
)
BRIEF-Cleveland Biolabs Inc's principal financial officer resigns -...
www.reuters.com
June 2 (Reuters) - Cleveland Biolabs Inc: * Cleveland Biolabs Inc - On May 29, John Szydlo notified co that he will resign as company's principal financial officer, effective June 16. * Cleveland Biolabs Inc - Yakov Kogan, company's chief executive officer, will serve as interim principal financial officer ...
Cleveland BioLabs Reports Appointment of CEO and Provides ...
www.globenewswire.com
Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that the Company's Board of Directors appointed Yakov Kogan, Ph.D., MBA, as CBLI's Chief Executive Officer. Dr. Kogan had served as interim Chief Executive Officer ...
Cleveland BioLabs Launches Updated Website (Nasdaq:CBLI)
www.globenewswire.com
Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, "Since the launch of our prior website, the breadth of our drug candidate pipeline has expanded and we have matured into a clinical-stage oncology company.
Cleveland BioLabs Reports Strong Survival Results Which Met the ...
www.globenewswire.com
Yakov Kogan, Ph.D., MBA, interim Chief Executive Officer, commented: "I congratulate our team on the rigorous execution of this study. To our knowledge, this trial is the first ever GLP/GCP compliant, randomized, blinded ...
sorted by relevance / date